Fineline Cube

Follow:
14486 Articles
MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors
CompanyDeals

MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors

Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500
CompanyDeals

Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500

CSPC's Prusogliptin Approved in China for Type 2 Diabetes Treatment
CompanyDrug

CSPC’s Prusogliptin Approved in China for Type 2 Diabetes Treatment

3SBio Acquires Licensing Rights to Duality Biologics' HER2-Targeting ADC DB-1303
CompanyDeals

3SBio Acquires Licensing Rights to Duality Biologics’ HER2-Targeting ADC DB-1303

CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion
CompanyDeals

CBC Group’s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion

JW Therapeutics' Carteyva Granted Breakthrough Therapy Designation by CDE
CompanyDrug

JW Therapeutics’ Carteyva Granted Breakthrough Therapy Designation by CDE

CSPC Pharmaceutical's ADC Pipeline Advances with SYS 6041 Approval
CompanyDrug

CSPC Pharmaceutical’s ADC Pipeline Advances with SYS 6041 Approval

Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
CompanyDeals

Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership

Johnson & Johnson MedTech's Dual Energy Catheter Gains CE Mark
CompanyMedical Device

Johnson & Johnson MedTech’s Dual Energy Catheter Gains CE Mark

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study
CompanyDrug

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study

Mabworks Biotech Licenses Anti-APRIL mAb to Climb Bio for Global Development
CompanyDeals

Mabworks Biotech Licenses Anti-APRIL mAb to Climb Bio for Global Development

Gilead Sciences and LEO Pharma Alliance Targets Inflammatory Diseases
CompanyDeals

Gilead Sciences and LEO Pharma Alliance Targets Inflammatory Diseases